Thye Dirk — SEC Form 4 filings
SEC reporting owner CIK 1638945. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-23.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-17 to 2026-01-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 154,500 shares, $107,375 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 77,000 shares @ $0.70 ($53,900) in Quince Therapeutics, Inc., filed 2024-09-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | CEO and CMO, Director | 7 | 2 legs · 154,500 sh · $107,375 | — | 11 |
Form 4 filings — Thye Dirk
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-23 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | Quince Therapeutics, Inc. (QNCX) | Gift (G): 739,885 @ $0 · Gift (G): 739,885 @ $0 | EDGAR |
| 2025-06-23 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 150,944 @ $1.20 · Grant/award (A): 150,944 (derivative) @ $0.12 | EDGAR |
| 2025-02-11 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 1,200,000 (derivative) @ $0 | EDGAR |
| 2024-09-03 | 4 | Quince Therapeutics, Inc. (QNCX) | Purchase (P): 77,500 @ $0.69 · Purchase (P): 77,000 @ $0.70 | EDGAR |
| 2024-02-02 | 4 | Quince Therapeutics, Inc. (QNCX) | Grant/award (A): 1,500,000 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | Quince Therapeutics, Inc. (QNCX) | Option exercise (M): 90,531 @ $0.55 · Option exercise (M): 149,999 @ $0.94 · Option exercise (M): 90,531 (derivative) @ $0 · Option exercise (M): 149,999 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1638945 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →